The Mission of the Pulmonary, Critical Care, Allergy and Sleep Medicine Program is to be a leader in the provision of comprehensive medical care to patients with pulmonary disease, critical illness, allergic diseases and sleep disorders, to be an engine for innovative research aimed at elucidating basic mechanisms of disease, to translate our research activities into new clinical initiatives, and to provide a rich training environment for the next generation of international leaders in basic, translational and clinical research.
Featured Videos View All »
Video
Lung Transplant Candidates: Shining a Light on UCSF’s Evaluation Process
In this short presentation, pulmonologist Jeffrey A. Golden, MD, describes how the specialists of the UCSF Lung Transplant Program work together to ensure their patients are likely to succeed, with a focus on factors that can make or break survival prospects.
Video
The COPD Blues: A Guide to Optimizing Outpatient Management
For the 30 million adults in the U.S. with COPD, effective care requires providers to have an up-to-date understanding of treatment options as well as the ability to respond to changes in a patient’s status.
Video
Breathing Easier: An Update on Diagnosis and Management of Asthma
Allergist and immunologist Monica Tang, MD, discusses keys to distinguishing asthma from other disorders.
Video
Long COVID: A New Way to Look at a Growing Problem
Synthesizing multiple studies, pulmonologist Brian Block, MD, reveals which patients are at risk for lasting symptoms from infection with the coronavirus (it’s not who you might think).
Articles & Documents View All »
News
Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the ...
News
New Research on Cell Regeneration Shows Promise for Treating Lung Injury and Fibrosis
In a new study, UCSF researchers showed that they could successfully redirect profibrotic murine lung cells to a nonfibrotic state in which they regenerated alveoli. These findings could lead to novel treatments for lung injury and fibrosis.
News
UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life
Hospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years Later
News
In a collaborative study between UCSF researchers appearing December 30 in Nature Cell Biology, UCSF researchers Jaymin Kathiriya, PhD, and Chaoqun Wang, PhD, discovered that severe lung injuries can trigger lung stem cells to undergo ...
The Mission of the Pulmonary, Critical Care, Allergy and Sleep Medicine Program is to be a leader in the provision of comprehensive medical care to patients with pulmonary disease, critical illness, allergic diseases and sleep disorders, to be an engine for innovative research aimed at elucidating basic mechanisms of disease, to translate our research activities into new clinical initiatives, and to provide a rich training environment for the next generation of international leaders in basic, translational and clinical research.
